Michael has studied chemistry and biology with a Ph.D. from ETH Zurich. He has significant experience from previous R&D roles at leading industrial Life Science organisations in metabolic and cardiovascular health.
A serial entrepreneur, Michael has led several start-up companies to profitability, including Siegfried Biologics, Kuros Biosciences and ChromaCon. Besides his assignment with Galventa, Michael is engaged in helping a Venture boutique company, Remora Capital to launch new start-up companies in the field of Cancer/Immunology and Healthy Aging.
Having a specific interest in nutraceuticals and healthy aging, Michael works on developing new products, focusing on manufacturing, regulatory and quality issues.
Michael supports organizations for disabled children and likes to meet his friends and extended family members to celebrate occasions as they occur. Michael enjoys studying art and history of late antiquity and is fond of classical music.